Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.[2]
Altria is the parent company of Philip Morris USA, John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., Philip Morris Capital Corporation, and NJOY Holdings, Inc. Altria also maintains large minority stakes in Belgium-based brewer AB InBev and the Canadian cannabis company Cronos Group. It is a component of the S&P 500 and was a component of the Dow Jones Industrial Average from 1985 to 2008, dropping due to spin-offs of Kraft Foods Inc. in 2007 and Philip Morris International in 2008.[3]
History
Altria emerged from Philip Morris USA. The onset of "rebranding" of Philip Morris Companies to Altria took place in 2003 (Philip Morris would later split, with Philip Morris USA remaining Altria's primary and only consistently held asset). According to Altria, it was created because Philip Morris wished to emphasize that its business portfolio had come to consist of more than Philip Morris USA and Philip Morris International; at the time, it owned an 84% stake in Kraft Foods,[4] although that business has since been spun off.[5] The name "Altria" is claimed to come from the Latin word for "high" and was part of a trend of companies rebranding to names that previously did not exist, Accenture (previously Andersen Consulting) and Verizon being notable examples,[6] though linguist
Finances
Altria and its predecessors is one of the best-performing publicly traded companies of the 20th century.[23]
For the fiscal year 2020, Altria reported earnings of US$4.45 billion, with an annual revenue of US$26.15 billion. Altria's shares traded at over $66 per share, and its market capitalization was valued at over US$118.5 billion in October 2018.[24] As of 2018, the company ranked 154th on the Fortune 500 list of the largest United States corporations by revenue.[25]
Corporate governance
Board of directors
Members of the board of directors of Altria Group as of February 2013 were:[27]
- Elizabeth E. Bailey, professor emerita, the Wharton School, University of Pennsylvania
- Gerald L. Baliles (2008–2019), director, Miller Center of Public Affairs at University of Virginia; former Virginia governor
- Martin Barrington, chairman and chief executive officer, Altria Group, Inc.
- John T. Casteen III (2010– ), president emeritus, University of Virginia
- Dinyar S. Devitre (2008– ), special advisor, General Atlantic Partners, New York, NY; former SVP and CFO of Altria
- Thomas F. Farrell II (2008–2021), chairman, president and CEO, Dominion Resources, Richmond, VA
Diversification
Altria, like other tobacco companies, has invested in science and medical companies which develop and produce medical products for conditions caused or aggravated by smoking.[31] As of 2024, Altria's three medical subsidiaries included the following: Cronos group (maker of recreational cannabis), Lexaria Bioscience (Developer of proprietary drug delivery technology, DehydraTECH, to improve active pharmaceutical ingredients entrance into the bloodstream) and Micreos (biotech company focused on discovering and developing recombinant proteins for chronic dermatology and oncology conditions).[31]
It has also designed and marketed electronic cigarettes. Altria launched the MarkTen and Green Smoke brands.[32] Both of these were discontinued in December 2018.[33] The company returned to this market through the acquisition of NJOY.[22]
Political influence
According to the Center for Public Integrity, Altria spent around $101 million on lobbying the United States government between 1998 and 2004, the second-highest such figure for any organization in the nation.[34][35]
Altria also funded The Advancement of Sound Science Coalition which lobbied against the scientific consensus on anthropogenic climate change.[36]
Daniel Smith, representing Altria, sits on the Private Enterprise Board of the American Legislative Exchange Council.[37]
In 2025, Altria was one of the donors funding the White House's East Wing demolition, and planned building of a ballroom.[38]
Controversies
In August 2006, the Altria group was found guilty of civil fraud and racketeering.[39][40] The lawsuit claimed that Altria's marketing of "light" and "low tar" cigarettes constituted fraudulent misrepresentations under the Maine Unfair Trade Practices Act (MUTPA) because it deceived smokers into thinking the products are safer than regular cigarettes.
See also
- Tobacco industry
- Tobacco Master Settlement Agreement
External links
- Altria Group U.S. political contributions from Influence Explorer at the Sunlight Foundation
References
- Altria Group, Inc. 2025 Annual Report (Form 10-K) U.S. Securities and Exchange Commission, February 25, 2026, retrieved March 23, 2026^
- Images - Altria www.altria.com, retrieved 2025-12-03^
- Altria, Honeywell Removed from DJIA; Bank of America, Chevron Added